Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2026-01-17 @ 12:38 PM
Study NCT ID:
NCT01026792
Status:
COMPLETED
Last Update Posted:
2015-09-10
First Post:
2009-12-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cervical Adenocarcinoma | View |
| None | Cervical Adenosquamous Carcinoma | View |
| None | Cervical Squamous Cell Carcinoma | View |
| None | Recurrent Cervical Carcinoma | View |
| None | Stage IIIA Cervical Cancer | View |
| None | Stage IIIB Cervical Cancer | View |
| None | Stage IVA Cervical Cancer | View |
| None | Stage IVB Cervical Cancer | View |
Keywords: